Bank of Montreal’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,531
Closed -$265 4344
2022
Q3
$265 Buy
+6,531
New +$266K ﹤0.01% 3019
2021
Q2
Sell
-60
Closed -$8K 5006
2021
Q1
$8K Sell
60
-232
-79% -$48.9K ﹤0.01% 4478
2020
Q4
$65K Buy
292
+205
+236% +$39.6K ﹤0.01% 3818
2020
Q3
$18K Sell
87
-64
-42% -$14.3K ﹤0.01% 3888
2020
Q2
$42K Buy
+151
New +$40.2K ﹤0.01% 3510
2020
Q1
Sell
-173
Closed -$64K 4800
2019
Q4
$64K Buy
173
+52
+43% +$14.9K ﹤0.01% 3726
2019
Q3
$39K Buy
121
+7
+6% +$2.38K ﹤0.01% 3745
2019
Q2
$40K Buy
+114
New +$44.8K ﹤0.01% 3803
2019
Q1
Sell
-13
Closed -$5K 4807
2018
Q4
$5K Buy
13
+9
+225% +$3.4K ﹤0.01% 4109
2018
Q3
$2K Hold
4
﹤0.01% 4405
2018
Q2
$2K Sell
4
-274
-99% -$98.1K ﹤0.01% 4411
2018
Q1
$94K Buy
+278
New +$93.5K ﹤0.01% 2987

Other funds holding QTTB

Bank of Montreal's QTTB Position: Q4 2022 in Review

Bank of Montreal sold out of Q32 Bio (QTTB) in Q4 2022, closing a stake of 6,531 shares — an estimated $265 sold.

Bank of Montreal first reported a position in QTTB in Q1 2018 and held it in 12 quarters. The position peaked at $94K in Q1 2018. 79 funds tracked by Wall St. Rank hold QTTB as of Q4 2022.

  • Bank of Montreal reported no remaining Q32 Bio position as of Q4 2022 after selling out during the quarter.
  • Bank of Montreal sold 6,531 Q32 Bio shares in Q4 2022, an estimated $265.
  • Bank of Montreal first reported a position in Q32 Bio in Q1 2018 and held it in 12 quarters.
  • Bank of Montreal's Q32 Bio position peaked at $94K in Q1 2018.
  • 79 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2022.

Based on Bank of Montreal's 13F filing for Q4 2022, filed 1 Feb 2023.